Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.14% |
| 2 | Financials | 4.52% |
| 3 | Industrials | 4.17% |
| 4 | Healthcare | 3.91% |
| 5 | Consumer Discretionary | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
CALL
Colgate-Palmolive
CL
$73.7B
| $17.5M | 0.01% |
254,900
-113,000
| -31% | -$7.7M |
|
|
ITCI
1502
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $17.5M | 0.01% |
511,100
+451,900
| +763% | +$5.42M |
|
1503
Visteon
VC
$2.77B
| $17.5M | 0.01% |
202,509
-728,398
| -78% | -$64.9M |
|
1504
HSBC
HSBC
$352B
| $17.5M | 0.01% |
448,369
-178,019
| -28% | -$6.75M |
|
1505
Cactus
WHD
$5.47B
| $17.5M | 0.01% |
510,536
-1,007,715
| -66% | -$30.6M |
|
1506
PUT
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$313M
| $17.5M | 0.01% |
659,900
+75,200
| +13% | +$1.92M |
|
1507
PUT
Axsome Therapeutics
AXSM
$11B
| $17.5M | 0.01% |
169,000
+91,000
| +117% | +$3.68M |
|
1508
Ironwood Pharmaceuticals
IRWD
$706M
| $17.5M | 0.01% |
1,312,165
-1,266,004
| -49% | -$14M |
|
1509
PUT
ProShares UltraPro Short QQQ
SQQQ
$1.77B
| $17.5M | 0.01% |
1,247
+789
| +172% | +$13.5M |
|
1510
Vanguard FTSE Pacific ETF
VPL
$8.32B
| $17.5M | 0.01% |
250,803
+150,951
| +151% | +$10.4M |
|
1511
PUT
Albemarle
ALB
$15.2B
| $17.4M | 0.01% |
238,800
-32,700
| -12% | -$2.18M |
|
1512
CALL
DaVita
DVA
$11.5B
| $17.4M | 0.01% |
232,200
-141,500
| -38% | -$9.39M |
|
1513
CALL
Tilray
TLRY
$614M
| $17.4M | 0.01% |
101,700
+1,680
| +2% | +$347K |
|
1514
Match Group
MTCH
$8.52B
| $17.4M | 0.01% |
211,675
-625,528
| -75% | -$45.5M |
|
1515
CALL
Old National Bancorp
ONB
$10.3B
| $17.4M | 0.01% |
950,300
-497,800
| -34% | -$8.94M |
|
1516
FS KKR Capital
FSK
$3.32B
| $17.3M | 0.01% |
706,937
+221,764
| +46% | +$5.3M |
|
1517
CALL
Nutanix
NTNX
$16.2B
| $17.3M | 0.01% |
554,400
+203,000
| +58% | +$5.99M |
|
1518
CALL
Xerox
XRX
$427M
| $17.3M | 0.01% |
469,800
+302,700
| +181% | +$10.6M |
|
1519
Charles River Laboratories
CRL
$12.5B
| $17.3M | 0.01% |
+113,373
| New | +$15.7M |
|
1520
CALL
Viatris
VTRS
$19.8B
| $17.3M | 0.01% |
861,200
-250,000
| -22% | -$4.65M |
|
1521
PUT
TAL Education Group
TAL
$6.75B
| $17.3M | 0.01% |
359,000
-109,600
| -23% | -$4.71M |
|
1522
PUT
Royal Gold
RGLD
$18.4B
| $17.2M | 0.01% |
141,000
+22,300
| +19% | +$2.64M |
|
1523
CALL
Bunge Global
BG
$20.9B
| $17.2M | 0.01% |
299,500
+41,700
| +16% | +$2.31M |
|
1524
PUT
Chewy
CHWY
$9.65B
| $17.2M | 0.01% |
594,200
+6,400
| +1% | +$164K |
|
1525
JPMorgan BetaBuilders Japan ETF
BBJP
$18.5B
| $17.2M | 0.01% |
350,880
+144,673
| +70% | +$7.14M |
|
Similar funds
Citadel Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Citadel Advisors held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Industrials.
Against the trend, Citadel Advisors opened a new position in Interxion Holding N.V. worth $83.9M.
- Citadel Advisors's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Citadel Advisors added most to Amazon in Q4 2019, an estimated $615M increase.
- Citadel Advisors's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Citadel Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Citadel Advisors's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Citadel Advisors opened 1,220 new positions and closed 1,266 in Q4 2019.
- Citadel Advisors's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.